全文获取类型
收费全文 | 20611篇 |
免费 | 2748篇 |
国内免费 | 1125篇 |
专业分类
耳鼻咽喉 | 102篇 |
儿科学 | 206篇 |
妇产科学 | 180篇 |
基础医学 | 2880篇 |
口腔科学 | 393篇 |
临床医学 | 1906篇 |
内科学 | 2630篇 |
皮肤病学 | 259篇 |
神经病学 | 1893篇 |
特种医学 | 217篇 |
外国民族医学 | 5篇 |
外科学 | 1281篇 |
综合类 | 3042篇 |
现状与发展 | 3篇 |
预防医学 | 855篇 |
眼科学 | 418篇 |
药学 | 3913篇 |
19篇 | |
中国医学 | 2286篇 |
肿瘤学 | 1996篇 |
出版年
2024年 | 222篇 |
2023年 | 775篇 |
2022年 | 1368篇 |
2021年 | 1640篇 |
2020年 | 1471篇 |
2019年 | 1028篇 |
2018年 | 974篇 |
2017年 | 996篇 |
2016年 | 1072篇 |
2015年 | 1032篇 |
2014年 | 1511篇 |
2013年 | 1818篇 |
2012年 | 1422篇 |
2011年 | 1359篇 |
2010年 | 883篇 |
2009年 | 853篇 |
2008年 | 748篇 |
2007年 | 700篇 |
2006年 | 547篇 |
2005年 | 478篇 |
2004年 | 387篇 |
2003年 | 344篇 |
2002年 | 237篇 |
2001年 | 237篇 |
2000年 | 191篇 |
1999年 | 178篇 |
1998年 | 163篇 |
1997年 | 156篇 |
1996年 | 141篇 |
1995年 | 123篇 |
1994年 | 122篇 |
1993年 | 122篇 |
1992年 | 106篇 |
1991年 | 98篇 |
1990年 | 75篇 |
1989年 | 71篇 |
1988年 | 92篇 |
1987年 | 71篇 |
1986年 | 70篇 |
1985年 | 81篇 |
1984年 | 75篇 |
1983年 | 61篇 |
1982年 | 74篇 |
1981年 | 64篇 |
1980年 | 52篇 |
1979年 | 32篇 |
1978年 | 35篇 |
1977年 | 18篇 |
1976年 | 25篇 |
1973年 | 19篇 |
排序方式: 共有10000条查询结果,搜索用时 11 毫秒
71.
上皮间质转化(EMT)及其分子机制 总被引:7,自引:0,他引:7
上皮细胞受到细胞外因子刺激后向间质细胞转化的现象与肿瘤的浸润转移密切相关。在此过程中上皮细胞的极性丧失,迁移和运动能力增强,同时上皮表型丢失而逐渐获得间质表型。参与这一过程的细胞内信号转导途径有受体酪氨酸激酶Ras-MAPK途径,Src激酶,Rho家族激酶,PI3K/AKT途径,Wnt信号通路,转录因子等。 相似文献
72.
VRML metabolic network visualizer 总被引:1,自引:0,他引:1
Rojdestvenski I 《Computers in biology and medicine》2003,33(2):169-182
73.
胸腹水组织因子及组织因子途径抑制物的检测及其意义 总被引:2,自引:0,他引:2
目的研究三组疾病胸腹水组织因子(Tissue factor,TF)及组织因子途径抑制物(Tissue factor pathway inhibitor,TFPI)的表达及其鉴别诊断意义。方法TF和TFPI采用ELISA法测定抗原表达。结果胸腹水TF水平和TFPI水平,恶性肿瘤组(570.04±627.53)ng/L,(28.60±15.57)μg/L和结核病组(283.82±143.16)ng/L,(31.16±12.26)μg/L明显高于肝硬化组(60.83±66.87)ng/L,(7.84±5.45)μg/L,P<0.01。TF/TFPI比值则为恶性肿瘤组(32.17±44.19)明显高于结核病组(13.55±13.15)和肝硬化组(11.22±9.05,P<0.05)。在恶性肿瘤组中,胸腹水癌细胞阳性组的TF表达(1106.92±1244.28)ng/L高于阴性组(331.08±295.84)ng/L,P<0.05。而阳性组的TFPI水平(27.35±17.75)μg/L与阴性组(30.34±13.20)μg/L无明显差异(P>0.05)。TF/TFPI比值则为阳性组(59.59±65.10)明显高于阴性组(11.54±8.37,P<0.01)。结论检测胸腹水TF和TFPI并分析TF/TFPI比值可以作为临床实验室有鉴别诊断意义的辅助指标,同时还可了解疾病的某些病理机制,尤其是肿瘤的某些生物学行为。 相似文献
74.
The cardiac neural crest is located in a transitional area on the neuraxis between trunk and cephalic regions and gives rise to both the dorsolateral and ventrolateral crest cell populations. Around stage 18 of chick development, a mass of E/C8+ cells surrounds the postotic pharyngeal arches and forms a crescent-shaped arch, termed the circumpharyngeal ridge. Using immunohistochemistry and quail-chick chimeras, it was determined that the E/C8+ cell mass located in the circumpharyngeal ridge derives from the dorsolateral component of the cardiac neural crest. The ventrolateral cell population of the cardiac crest is located more medially and shows long-persistent HNK-1 immunoreactivity dorsolateral to the foregut. The crest cells that populate the gut arise from the caudal portion of the circumpharyngeal crest and are always located caudal to the caudalmost pharyngeal ectomesenchyme. Circumpharyngeal crest cells continuously populate the pharyngeal arch ectomesenchyme and enteric nervous system on the lateral side of the foregut wall, as well as the hypoglossal pathway which develops within the ventral portion of the circumpharyngeal ridge. E/C8 and HNK-1 immunoreactivity are associated with the cells migrating via the dorsolateral (circumpharyngeal) and ventrolateral pathways, respectively, with one exception: there is a population of putative crest cells along the proximal course of the vagal intestinal branch that shows both immunoreactivities around stage 20. Dil labeling of the cells in the circumpharyngeal ridge suggests that the cells are contributed from the circumpharyngeal ridge to this population. Thus, the distribution of the circumpharyngeal crest cells and their derivatives coincides with the peripheral branch distribution of the cranial nerves IX, X, and XII, whose development is selectively affected in the absence of the cardiac neural crest, the source of the circumpharyngeal crest.© Willey-Liss, Inc. 相似文献
75.
P. A. T. Kelly F. H. Gage M. Ingvar O. Lindvall U. Stenevi A. Björklund 《Experimental brain research. Experimentelle Hirnforschung. Expérimentation cérébrale》1985,58(3):570-579
Summary Transection of the septo-hippocampal connections through fimbria-fornix damage in the rat results in profound hippocampal cholinergic deafferentation, and, when applied bilaterally, leads to severe and long-lasting impairments in learning and memory. Previous studies have shown that intrahippocampal septal grafts can reestablish a new cholinergic innervation in the inititally denervated hippocampal formation and at least partly compensate for the lesion-induced learning impairments in fimbria-fornix lesioned rats. The purpose of the present study was to determine the magnitude of lesion-induced alterations in cerebral function as reflected in local glucose use measured by (14C)-2-deoxyglucose (2-DG) autoradiography, and the degree to which this index of functional activity could be normalized following reinnervation from transplants of fetal cerebral tissue from the primordial septal region. Six months after unilateral fimbriafornix transection the rate of glucose utilization was reduced markedly throughout the ipsilateral hippocampus when compared to the intact contralateral side, while in the neocortex only the cingulate cortex showed long-lasting reductions in glucose use. Rats that received a transplant of fetal septal-diagonal band tissue at the time of fimbria-fornix transection, and were sacrificed 6 months later, displayed significantly greater glucose utilization in the ipsilateral hippocampus and cingulate cortex than was measured in these areas in rats with lesion alone. The recovery in glucose use was paralleled by a significant increase in acetylcholinesterase (AChE) staining in several areas of the ipsilateral hippocampal formation and cingulate cortex. This index of graft-induced cholinergic reinnervation was, moreover, significantly correlated with the rate of glucose use. Thus, in the fimbria-fornix transected animals the magnitude of glucose depression correlated with the extent of reduction in AChE staining, and in the grafted animals the degree of normalization of glucose use was correlated with the graft-induced increase in AChE-staining density. These results thus indicate that the 2-DG autoradiographic technique can provide a unique opportunity to map both altered functional activity in localized areas of the brain following specific lesions and the extent to which transplant-derived reinnervation of the host may induce a return to normal functional levels in the target site.ETP and Royal Society (London) visiting fellow 相似文献
76.
浸润和转移是恶性肿瘤的重要特征,也给肿瘤的治疗带来困难,是预后不良的重要因素.转移抑制因子23(non-metastasis,NM23)基因是最早发现的抗肿瘤转移基因之一.现在已经发现NM23是一个基因家族,包括NM23-H1、NM23-H2等重要的基因家族成员.研究表明NM23基因表达与实体瘤转移抑制有关,在很多实体瘤中可以作为进展和预后的分子标记.随着对NM23基因调控肿瘤转移的分子机制的研究的进一步开展,已经发现了一些NM23肿瘤转移抑制通路上下游的相关调控分子,为进一步的信号通路研究创造了条件.本文概述了近年来对NM23基因转移抑制通路研究的新近展,提出了以后可能的研究方向和需要解决的关键问题. 相似文献
77.
Andrea M. Gross Megan Frone Karen W. Gripp Bruce D. Gelb Lisa Schoyer Lisa Schill Beth Stronach Leslie G. Biesecker Dominic Esposito Edjay Ralph Hernandez Eric Legius Mignon L. Loh Staci Martin Deborah K. Morrison Katherine A. Rauen Pamela L. Wolters Dina Zand Frank McCormick Sharon A. Savage Douglas R. Stewart Brigitte C. Widemann Marielle E. Yohe 《American journal of medical genetics. Part A》2020,182(4):866-876
RASopathies caused by germline pathogenic variants in genes that encode RAS pathway proteins. These disorders include neurofibromatosis type 1 (NF1), Noonan syndrome (NS), cardiofaciocutaneous syndrome (CFC), and Costello syndrome (CS), and others. RASopathies are characterized by heterogenous manifestations, including congenital heart disease, failure to thrive, and increased risk of cancers. Previous work led by the NCI Pediatric Oncology Branch has altered the natural course of one of the key manifestations of the RASopathy NF1. Through the conduct of a longitudinal cohort study and early phase clinical trials, the MEK inhibitor selumetinib was identified as the first active therapy for the NF1‐related peripheral nerve sheath tumors called plexiform neurofibromas (PNs). As a result, selumetinib was granted breakthrough therapy designation by the FDA for the treatment of PN. Other RASopathy manifestations may also benefit from RAS targeted therapies. The overall goal of Advancing RAS/RASopathy Therapies (ART), a new NCI initiative, is to develop effective therapies and prevention strategies for the clinical manifestations of the non‐NF1 RASopathies and for tumors characterized by somatic RAS mutations. This report reflects discussions from a February 2019 initiation meeting for this project, which had broad international collaboration from basic and clinical researchers and patient advocates. 相似文献
78.
The major phospholipids present in the phospholipid extract of Schistosoma mansoni were phosphatidylcholine (28%), phosphatidylethanolamine (25%), phosphatidylserine (15%) and phosphatidylglycerol (8%). The synthesis of phosphatidylcholine in S. mansoni adults occurred by the choline to phosphatidylcholine or Kennedy pathway. Incorporation of CDPcholine and choline into the phosphatidylcholine of worm slices appeared linear over time with no demonstrable sex differences in choline incorporation. A slight difference in the incorporation of CDPcholine by separate sexes was evident. Methylation of phosphatidylethanolamine to phosphatidylcholine could not be demonstrated. 相似文献
79.
补体经典激活途径C3转化酶的体外组装及活性观察 总被引:1,自引:0,他引:1
目的:体外组装包含人C4分子的补体经典激活途径C3转化酶,并对其转化酶活性及衰变特性进行观察。方法:利用豚鼠血清功能纯C1、C2及溶血中间体EAC4^hu体外组装经典途径C3转化酶,观察不同C1、C2用量及孵育温度对C3转化酶形成和自发性衰变的影响,以及人红细胞膜抽提蛋白对C3转化酶衰变化的影响。结果:高剂量和低剂量的C1均会影响C3转化酶的形成,增加C2用量可增加C3转化酶的形成数量,C3转化酶的自发性衰变随孵育温度的升高而加速,人红细胞膜抽提蛋白可抑制C3转化酶的自发性衰变过程,结论:C1、C2用量及孵育温度是影响C3转化酶形成和自发性衰变的主要因素,体外组装的补体经典激活途径C3转化酶可应用于相关补体调控蛋白的活性检测。 相似文献
80.